Caspases 3, p53, and NF-κB are potential therapeutic targets for various types of cancers, including breast cancer, lung cancer, leukemia, lymphoma, colon cancer, ovarian cancer, prostate cancer, and hematologic malignancies like leukemia, lymphoma, and multiple myeloma [9–14]. The gene discussed is NFKB1; the disease is breast carcinoma.